Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28365013 | 0.98 | MMP8 (0.66) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL266419 | 0.90 | MMP8 (0.74) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL28674585 | 0.89 | MMP8 (0.72) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL31069943 | 0.89 | MMP8 (0.72) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL1275691 | 0.87 | MMP8 (0.70) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL15024699 | 0.86 | ALDH1A1 (0.53) | MMP8SMN1; SMN2SRC | |
| SCHEMBL6959479 | 0.85 | MMP8 (0.68) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL28464077 | 0.85 | MMP8 (0.50) | MMP8KMT2AMEN1NPC1CA12 | |
| SCHEMBL28474562 | 0.85 | MMP8 (0.73) | MMP8KMT2AMEN1NPC1CA12 | |
| Hydrochloric Acid SCHEMBL10677191 | 0.85 | MMP8 (0.68) | MMP8KMT2AMEN1NPC1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115068619-B | Preparation method of photo-thermal dual-response composite carrier, prepared composite carrier and application of composite carrier | 北京化工大学 | 2024-01-30 | — | — | CN | claimed |
| CN-115605036-A | Light emitting device, display panel, manufacturing method of display panel and display device | 京东方科技集团股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-112225721-B | Acid-responsive near-infrared lysosome organic small-molecule fluorescent probe and preparation method and application thereof | 复旦大学 | 2021-09-17 | — | — | CN | claimed |
| CN-112225721-A | Acid-responsive near-infrared lysosome organic small-molecule fluorescent probe and preparation method and application thereof | 复旦大学 | 2021-01-15 | — | — | CN | claimed |
| CN-210058251-U | Production device of ethyl phenylacetate | 辽宁先达农业科学有限公司 | 2020-02-14 | — | — | CN | claimed |
| EP-2308829-B1 | A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | JIANGSU HENGRUI MEDICINE CO (CN) | 2017-06-14 | — | — | EP | claimed |
| US-20160152825-A1 | PROCESS FOR PRODUCING COMPOSITES | EVONIK DEGUSSA GMBH (DE) | 2016-06-02 | — | — | US | claimed |
| EP-3026072-A1 | Method for the preparation of composites | Evonik Degussa GmbH (DE) | 2016-06-01 | — | — | EP | claimed |
| US-8580997-B2 | Process for preparing R-beta-amino phenylbutyric acid derivatives | JIANGSU HENGRUI MEDICINE CO. LTD. (CN) | 2013-11-12 | — | — | US | claimed |
| US-20110130587-A1 | PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2011-06-02 | — | — | US | claimed |
| EP-2308829-A1 | A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2011-04-13 | — | — | EP | claimed |
| JP-7101946-A | — | — | None | — | — | JP | disclosed |
| CN-115068619-B | Preparation method of photo-thermal dual-response composite carrier, prepared composite carrier and application of composite carrier | 北京化工大学 | 2024-01-30 | — | — | CN | disclosed |
| US-11884837-B2 | Scratch and mar resistant automotive coatings | BASF COATINGS GMBH (DE) | 2024-01-30 | — | — | US | disclosed |
| US-20230219978-A1 | COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF | SCINNOHUB PHARMACEUTICAL CO., LTD (CN) | 2023-07-13 | — | — | US | disclosed |
| US-4007180-A | POLYESTERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-02-08 | — | — | US | disclosed |
| US-4005215-A | DIURETIC | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-25 | — | — | US | disclosed |
| US-4000122-A | BACTERICIDES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-3978077-A | DIURETIC, HYPOTENSIVE, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (GB) | 1976-08-31 | — | — | US | disclosed |
| US-3957814-A | DIURETICS, SALURETICS, HYPOTENSIVE AGENTS, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219978-A1 | COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF | BTK, SRC, YES1 | MMP8 3859/4885KMT2A 1866/4885MEN1 306/4885 |
| US-20110130587-A1 | PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | ALAD, DAO, DDO | MMP8 4805/4885KMT2A 3270/4885MEN1 4807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.